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ABSTRACT 
Purpose: We describe a select group of asymptomatic patients wi th  fragments a n d  dust 3 
months after extracorporeal treatment,  who were followed to  evaluate the long-term outcome and 
therapeutic implications. 
Materials a n d  Methods: A total of 129 patients with dust and residual fragments (less than 4 
mm.) at 3 months was  re-examined at 12 months, and 95 were also evaluated at 24  months.  
Followup examinations consisted of radiographic studies, renal ultrasonography and urine 
culture. Dus t  a n d  residual fragments were sought, and patients were defined as free or as having  
persistent lithiasis or stone regrowth. At 24 months  recurrences in the patients stone-free at 1 2  
months also were considered. 
Results: At the 12-month followup 60 patients (46.5%) were stone-free and 56 (43.5%) still had 
dust or  residual fragments. The localization of the stones o r  fragments at 3 months  a n d  their 
sizes did not have a significant influence on the stone-free rate but regrowth was greater in 
patients with stones larger t h a n  10  mm. (11 of 40 patients, 27.5% versus 2 of 89,2.2%, p = 0.001). 
The probability of eliminating residual lithiasis at 12 months  was  significantly greater in 
patients with dust than in those with residual fragments (42  of 79 patients, 58% versus 18 of 50, 
36%, p = 0.026). Regrowth of residual lithiasis was  observed in 13 patients (10%). 
Conclusions: Based on ou r  results, we do not believe that patients with fragments require 
systematic re-treatment in the short  term but they  may  be followed long te rm and re-treated if 
symptoms persist or stones recur. 
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The therapeutic efficacy of shock wave lithotripsy in the 
treatment of renal and ureteral stones is undisputed 15 years 
after its introduction in clinical practice.’ This method rep- 
resents a revolution in the management of patients with 
lithiasis.2 However, since the first large series was presented, 
evaluation of the results of extracorporeal treatment has 
been controversial. Still more controversial is the approach to 
patients whose stones are not completely eliminated but in 
whom small fragments (less than 5 mm.) or dust persists, 
defined by some authors as clinically insignificant residual 
fragments.3-7 Such fragments are found at the renal level in 
851c of patients at  discharge after extracorporeal treatment, 
and are considered a factor that favors progression of lithia- 
sis,R.g and an increased risk for significant symptomatic ep- 
isodes or need for intervention.10 We describe a select group 
of asymptomatic patients with fragments and dust 3 months 
after extracorporeal treatment, who were followed to evalu- 
ate the long-term outcome and therapeutic implications. 
PATIENTS AND METHODS 
For this study we considered 467 patients who underwent 
treatment with Dornier HM3 modified and MPL 9000 litho- 
triptors for a single radiopaque renal stone 15 mm. or less 
between 1991 and 1994. Other selection criteria were the 
absence of morphological alterations of the urinary system as 
shown on pretreatment excretory urography and ultrasonog- 
raphy, no previous urinary tract surgery, no history of in- 
fection stones and negative urine culture before treatment. 
Patients with definite metabolic disease, such as hyperpara- 
thyroidism and renal tubular acidosis, were also excluded. 
Thus, we considered only patients with simple renal lithiasis 
in the presence of normal renal morphology and function. 
Accepted for publication February 28, 1997. 
Three months aRer treatment the patients were assessed on 
the basis of a plain abdominal x-ray (including renal tomog- 
raphy), renal ultrasonography and urine culture, which re- 
vealed that 299 (64%) were stone-free, whereas 27 (6%) had 
residual fragments greater than 4 mm. or more and were 
sent for fbrther treatment. These 2 groups of patients were 
excluded from the study. The remaining 141 patients pre- 
sented with dust (shown radiologically to be uniformly dis- 
tributed in the cakes ,  87 cases, 62%) or single residual 
fragments of overall diameter of 4 mm. or less (54 patients, 
38%). Urine culture was positive in 12 patients despite the 
initial selection which excluded subjects with positive urine 
culture or a history of infection stones. All 12 patients re- 
ceived full doses of appropriate antibiotics but 7 still had a 
positive urine culture a t  the 12-month examination. Calcium 
oxalate and calcium phosphate were identified in these 
stones and urine colture did not reveal any urea-splitting 
bacterium, except Escherichia coli in 7 cases, Enterococcus in 
4 and Enterobacter in 1. 
A total of 69 women and 60 men, 19 to 80 years old (mean 
age plus or minus standard deviation 49.4 2 13.0), with dust 
and residual fragments at  3 months were reexamined at 12 
months, whereas 12 were lost to  followup and 95 were also 
evaluated at 24 months. Of the 129 patients studied 46 
(35.6%) had a history of stone with a stone relapse per year 
per patient index less than 0.2 with 60 previous stones. For 
this reason we considered our study population at a low risk 
for stone recurrence. 
Followup examinations consisted of radiographic studies, 
renal ultrasonography and urine culture. Dust and residual 
fragments were sought, and patients were defined as free or 
as having persistent lithiasis or stone regrowth (regrowth 
has been defined as any fragment size increment radiograph- 
ically evaluated a t  12 and 24-month followup). At 24 months 
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recurrences in the patients stone-free a t  12 months also were 
considered. In addition, we investigated the possibility that 
clearance of fragments could be correlated with localization 
of the stone before treatment or of the fragments 3 months 
after treatment, the size of the stone, the presence of dust or 
residual fragments and the occurrence of symptomatic epi- 
sodes related to  residual stones. The chi-square contingency 
table was used for statistical analysis. 
RESULTS 
The localization of the stones was pyelic in 34 of the 129 
patients (26.4%) who underwent the 12-month examination, 
upper caliceal in 16 (12.4%), mid caliceal in 17 (13.2%) and 
lower caliceal in 62 (48%). The maximum diameter of the 
treated stones varied from 5 to 15 mm. (mean 9.4 t 3.2). The 
localization of the fragments and dust 3 months after shock 
wave lithotripsy was upper caliceal in 10 patients (7.7%), mid 
caliceal in 34 (26.3%) and lower caliceal in 85 (66%) (table 1). 
At the 12-month followup 60 patients (46.5%) were stone-free 
and 56 (43.5%) still presented with dust or residual frag- 
ments. The initial stone localization from which fragments 
were most readily eliminated was the pelvis (67.6% of pa- 
tients became stone-free), followed by the upper, lower and 
mid calix (stone-free rates of 56,37.1 and 29.4%, respectively) 
(table 2). Considering instead the localization of fragments or 
dust 3 months after treatment, 70, 59 and 39% of patients 
with upper, mid and lower caliceal lithiasis became stone- 
free, respectively (table 3). The localization of the stones or 
fragments at 3 months and their sizes did not have a signif- 
icant influence on the stone-free rate but regrowth was 
greater in patients with stones larger than 10 mm. (11 of 40 
patients, 27.5% versus 2 of 89, 2.2%, p = 0.001, table 4). 
Fragment regrowth at 12-month followup did not show any 
significant difference between the group with or without 
history of stones. In the former group regrowth rate was 13% 
(6 of 46 patients) while in the latter it was 8.4% (7 of 83 
patients) (p = 0.27). The probability of eliminating residual 
lithiasis at  12 months was significantly greater in patients 
with dust than in those with residual fragments (42 of 79 
patients, 58% versus 18 of 50, 36%, p = 0.026) (table 5). 
Regrowth of residual lithiasis was observed in the lower 
calix in 12 cases and in the mid calix in 1, including 8 in 
which the initial localization of the stone was lower caliceal. 
Five patients had a positive urine culture at 3 and 12 
months. Of the remaining patients with a positive urine 
culture at 3 months 7 were stone-free at 12 months, including 
5 with a negative and 2 with a positive urine culture. Eight 
patients (6.2%) with stone regrowth underwent further shock 
wave lithotripsy, including 4 with symptoms, 3 with a posi- 
tive urine culture and 1 with a dilated calix due to obstruc- 
tion of the caliceal neck. Only 2 patients (25%) became com- 
pletely stone-free, including 1 with a positive urine culture 
that became negative. In the other cases the stone mass was 
reduced and the symptoms improved or resolved. 
Of the 129 patients 95 were available for followup 2 years 
after treatment, including 54 (56.8%) with residual lithiasis 
at 12 months, and 34 were lost to followup, including 15 with 
residual lithiasis, 18 stone-free and 1 with regrowth. At 2 
TABLE 1. Localization of  fra,qments and pre-lithotripsy stones 
he-lithotripsy Stones 
Fragment Total No. 
Localization Pelvis Upper Middle Lower (Q) 
Calix Calix Calk 
Upper calix 3 7 - - 10 (7.7) 
Mid calix 16 4 14 - 34 (26.3) 
Lower calix 15 5 3 62 ~ 85 (66) 
Total No. 34 (26.4) 16 (12.4) 17 (13.2) 62 (48) 129 (100) 
(Ye) 
TABLE 2. 12-Month followup results according to pretreatment 
stone localization 
Stone No' No. Unchanged Re:;th Total No 
Localization Sto?;ip Fragments 1% I 1% 1 % )  
Upper calix 9 (56.31 5 (31.31 2 112.61 16 (12.41 
Mid calix 5 129.41 11 (64.7, 1 15.91 17 113.2) 
Lower calix 23 137.11 31 1501 a(12.91 62(48.1) 
9 (26.5) 2 (5.81 34(26.41 Pelvis 
Total No. 60 (46.51 56143.51 13 (10) 129 (100) 
23 (67.61 
(%I 
TABLE 3. 12-Month followup results according to fragment 
localization 
Fragment No. Stone-Free No. Unchanged No. Regrowth 
Localization (7? 1 Fragments (5%) 1 % )  
Upper calix 7 (70) 3 (301 - 
Mid calix 20 (58.8) 13 (38.21 1 12.9) 
Lower calix 33 (38.8) 40 147) 12 (14.11) 
Total No. (%) 60 146.51 56 (43.5) 13 110) 
TABLE 4. 12-Month followup results according to pretreatment 
stone size 
Stone Size No.  Unchanged No. Regrowth No. Stone-Free Total No. 
(rnm.1 Framnents ( 9 )  (9 I (%)  (%I 
5 or Less 6 (43) - 8 (67) 14 I111 
6 1 0  41 (54.61 2 (2.7) 32(42.71 75 (58) 
20 (501 40 (31) 
Total No. (9 )  56 (43.5) 13 (10) 60 (46.5) 129 1100) 
- -  11-15 9 (22.5) 11 127.51* 
* p = 0.001. 
TABLE 5. 12-Month followup results according to the presence of 
dust or residual fragments 
No. Stone-Free No. Unchanged No. Regrowth Total No. 
(5%) Fragments 1 % )  1%) (0) 
Dust 42 153.21' 32 (40 5) 5 (6 31 79 (61 21 
8 1161 50i3881 Fragments 18 1361 24 (481 
~~ 
Total No. ( % j  60 (46.6) 56 (43.3) 13 1101 129 11OOl 
* p = 0.026. 
years 11 more patients were stone-free, increasing the over- 
all number in whom fragments were eliminated to 71 (55% of 
the subgroup with fragments at  3 months). Regrowth of 
fragments was observed in 5 other patients (5.2%). Two pa- 
tients (2.1%) with stone regrowth at 12 months that was not 
treated presented with increased regrowth, whereas re- 
growth in 2 others remained unchanged. Two patients stone- 
free a t  12 months had recurrence at 24 months. Of the 8 
patients who underwent further shock wave lithotripsy 2 
were stone-free and 6 had residual fragments at the 24- 
month examination (table 6). A total of 15 patients (11.6%) 
had symptoms, colic or low back pain, in the first year of 
followup. Overall, 14.7% of the patients had symptomatic 
events or required further treatment in the first year of 
followup. In the second year of followup 7.3% of patients (7) 
manifested pain symptoms. 
DISCUSSION 
Residual fragments represent a common and still contro- 
versial problem of extracorporeal treatment. Although effi- 
cacious fracture of stones into fragments less than 5 mm. has 
been described in 85%11 and 9692 of cases, 3 months &r 
extracorporeal treatment residual fragments were present in 
24 to 36%.3.11.12 Asymptomatic fragments less than 4 or 5 
mm. not associated with infection were initially defined 88 
clinically insignificant residual fragments. Regrowth of frag- 
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TABLE 6 2-Year followup results 
Fragments and Dust No Stone-Free No Unchanged No Regrowth No Recurrence Total NO 
9 I91 
Mid calm 22 175) 4 (13.8) 2 (7) 1 (3 4) 29 (31) 
Lower calix 23 I40 41 28 (49 11 1(17) 57 I601 
Localization (-<I Fragments ( cir I 1 % )  ( 5 % )  (%) 
- - Upper calm 8 I891 1 (11) 
Tota lNo I?, 53 I55 81 33 (34 81 7 17 3) 212 1) 95 (100, 
ments less than 4 mm. was reported by Newman e t  a1 in 
21.7% of their series at 1 year.13 Yu et a1 found an overall 
stone regrowth rate of 26% after a mean followup of 75 
months, and the regrowth of fragments correlated signifi- 
cantly with the size, site and multiplicity of stones.'* In a 
previous study of 247 patients we observed fragments less 
than 4 mm. in 36.6% of patients at 3 months, with a higher 
regrowth rate in patients treated for multiple, pyelocaliceal 
and lower caliceal stones.12 In these unselected series the 
regrowth of residual fragments present a t  3 months was 
70%14 and 64%,12 respectively, a t  long-term followup. Beck 
and Riehle reported that 47% of their patients treated with 
shock wave lithotripsy for infection stones was stone-free 
after a mean followup of 26.6 months, and 78% with frag- 
ments greater than 5 mm. and 48% with dust or fragments 
less than 4 mm. presented with disease progression in the 
long term." 
With the aim of improving the clearance of residual frag- 
ments various author+ 16. l6 have proposed early re- 
treatment, with complete elimination of stones or improve- 
ment in 40CTcL5 and 83%16 of the patients, but the systematic 
re-treatment of all asymptomatic patients was not justified 
by Newman et al.1:l On the other hand, Moon and Kim ob- 
served that re-treatment of even small fragments with a 
piezoelectric lithotriptor 1 month after the first treatment 
eliminated residual fragments in 9 2 4  of patients a t  6 months 
of fo l l~wup.~  Cicerello et a1 demonstrated that the adminis- 
tration of citrates resulted in clearance of residual fragments 
a t  12 months, increasing the stone-free rates from 32 to 74% 
in cases of sterile calcium oxalate stones and from 40 to 86% 
for infection stones.17 They also reported that clearance in 
patients with residual infection stone fragments may be im- 
proved by adequate chemotherapy. Fine et a1 suggested that 
appropriate medical treatment may be efficacious in the pro- 
phylaxis of recurrences and in reducing the proportion of 
patients with regrowth of residual fragments less than 5 mm. 
to 16%.9 More recently, based on a prospective study of 160 
patients who presented with dust or residual fragments less 
than 4 mm., Streem et a1 consider that  the description "clin- 
ically insignificant" applied to any residual stone after shock 
wave lithotripsy is likely a misnomer.10 In fact, 43% of the 
examined patients had symptomatic episodes or required 
intervention a t  a mean followup of 26 months. In the same 
period 23.8% of the patients became stone-free and 18% 
manifested fragment regrowth. 
In our select group of patients spontaneous elimination of 
fragments, particularly dust, was good a t  12-month followup 
(46.54). This rate, better than in other series including our 
own may be attributable to the selection of single stones less 
than 15 mm. with normal renal morphology. At 24-month 
followup only a further 8.5% of the patients became stone- 
free. On the other hand, symptomatic episodes occurred in 
about 19% of the patients by the 2-year followup, for a total 
of 22% of patients who had symptoms or required re- 
treatment. The decision to include patients in the study 3 
months after treatment probably decreased the proportion of 
symptomatic episodes and interventions due to the elimina- 
tion of most stones in the first months. Fragment regrowth 
was observed in 1 7 8  of the patients, particularly those who 
had pretreatment stones greater than 10 mm. and those who 
still had a positive urine culture a t  12 months. No urea- 
splitting germ was isolated in the latter group of patients and 
regrowth could not be attributed, in our opinion, to struvite 
deposition. On the other hand, urine stasis due to obstructing 
fragments, even if without gross urinary dilatation, can pro- 
mote infection and regrowth. The greater probabilities of 
regrowth of residual fragments are correlated in the litera- 
ture with the presence of infection stones, stone size and 
multiple stones. At present, however, the majority of stones 
treated a t  lithotripsy centers are less than 15 mm. about 80% 
of our cases, and mean stone size has decreased during the 
years. 
Our patients belong to a low recurrence risk population, 
and since a definite metabolic disease (hyperparathyroidism 
or tubular acidosis) was excluded a t  enrollment into the 
study, we did not perform a complete metabolic evaluation. 
We cannot definitively exclude an idiopathic metabolic dis- 
ease for which pharmacological therapy could be indicated to 
lower the relapse index or fragment regrowth9 but a high 
fluid intake regimen was recommended for every patient 
during followup. 
CONCLUSIONS 
Patients with fragments, like those included in our study, 
were stone-free within the first year after shock wave litho- 
tripsy but the stone-free rate was lower in the second year. 
Such patients may not require systematic re-treatment in 
the short term but in the long term re-treatment may be 
necessary if symptoms persist or stones recur. 
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EDITORIAL COMMENT 
This study of a highly selected group of patients with post-shock 
wave lithotripsy stone fragments addresses an  area of current con- 
troversy regarding the clinical significance of residual stone, and the 
need for secondary prophylactic intervention. The authors followed 
129 patients with stone fragments a t  3 months for another 1 to 2 
years to determine rates of symptomatic episodes, stone growth and 
stone recurrence. Inclusion in this study required treatment to a 
solitary stone measuring less than 1.5 cm. Patients with known 
metabolic disorders were specifically excluded. Results were strati- 
fied for initial stone burden and location, as  well as for size and 
location of the residual fragments. 
Of patients with residual fragments at 3 months posttreatment 
46.5% and 55% became stone-free after 1 and 2 years, respectively. 
Stone regrowth, while not well defined, was noted in 13% and 5% of 
patients at 1 and 2 years, respectively, and 214  had symptomatic 
episodes or required intervention during that time. The authors 
conclude that while patients such as  these with residual post-shock 
wave lithotripsy fragments do not require "systematic re-treatment," 
careful followup and subsequent medical therapy or urological inter- 
vention may be required. 
Their conclusions should be placed in perspective for this highly 
select group of patients. The study group was limited to patients with 
a solitary stone at the time of treatment, and patients with known 
metabolic disorders were excluded. As such, it is likely that rates of 
stone regrowth and recurrence, as well as  symptomatic episodes or 
need for intervention, would have been higher had these patients 
been more representative of a general stone population. However, it 
is also likely that the addition of medical therapy would impact 
positively on these results. Overall, this study appears to reinforce a 
growing consensus that, while any post-shock wave lithotripsy re- 
sidual stone may in fact become symptomatic, secondary more inva- 
sive intervention is generally not warranted prophylactically. 
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